These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 6177929)
21. Hemodynamic profile of KRN2391, a novel vasodilator, in anesthetized dogs. Ogawa N; Jinno Y; Kaneta S; Harada K; Fukata Y; Fukushima H J Cardiovasc Pharmacol; 1993 Jun; 21(6):874-82. PubMed ID: 7687711 [TBL] [Abstract][Full Text] [Related]
22. Comparison of two dihydropyridine calcium antagonists on coronary collateral blood flow in acute myocardial ischemia. Jolly SR; Hardman HF; Gross GJ J Pharmacol Exp Ther; 1981 Apr; 217(1):20-5. PubMed ID: 7205654 [TBL] [Abstract][Full Text] [Related]
23. Cardiovascular effects of a new dihydropyridine calcium antagonist. Kimura Y; Fukui H; Tanaka M; Okamoto M; Miura A; Kimura K; Enomoto H Arzneimittelforschung; 1986 Sep; 36(9):1336-44. PubMed ID: 3790183 [TBL] [Abstract][Full Text] [Related]
24. Effects of verapamil, nifedipine and flunarizine on haemodynamics and regional blood flows in pentobarbitone-anaesthetized rats. Waite RP; Pang CC; Walker MJ J Pharm Pharmacol; 1990 May; 42(5):325-31. PubMed ID: 1976779 [TBL] [Abstract][Full Text] [Related]
25. Comparison of cardiodepressant and vasodilator effects of PN 200-110 (isradipine), nifedipine and diltiazem in anesthetized rabbits. Hof RP Am J Cardiol; 1987 Jan; 59(3):37B-42B. PubMed ID: 2949587 [TBL] [Abstract][Full Text] [Related]
26. Comparative hemodynamic studies of isradipine and dihydralazine in atherosclerotic and normal rabbits. Hof RP; Hof A; Takiguchi Y J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S13-22. PubMed ID: 1695297 [TBL] [Abstract][Full Text] [Related]
27. Cardiovascular profile of FPL 62129, a novel dihydropyridine calcium channel blocker, in anaesthetised dogs: a comparison with nifedipine. Humphries RG; O'Connor SE J Cardiovasc Pharmacol; 1988 Mar; 11(3):332-8. PubMed ID: 2452927 [TBL] [Abstract][Full Text] [Related]
28. Effects of nilvadipine on the cardiovascular system in experimental animals. Ohtsuka M; Koibuchi Y; Sakai S; Tsujioka K; Fujiwara T; Ozaki T; Maeda K; Motoyama I; Horiai H; Ono T Arzneimittelforschung; 1988 Nov; 38(11):1605-18. PubMed ID: 3214444 [TBL] [Abstract][Full Text] [Related]
29. Antiischemic and hemodynamic effects of intravenous isradipine, a new calcium antagonist, in coronary heart disease: a comparative double-blind cross-over study with nifedipine. Burger W; Herholz H; Burger K; Kober G J Cardiovasc Pharmacol; 1990 Nov; 16(5):764-8. PubMed ID: 1703598 [TBL] [Abstract][Full Text] [Related]
30. Effects of niguldipine, a new dihydropyridine calcium antagonist, on regional blood flow, cardiac performance and myocardial metabolism in anaesthetized open-chest dogs. Fischer G; Schneider W; Krumpl G; Grohs JG; Raberger G Arch Int Pharmacodyn Ther; 1989; 298():96-107. PubMed ID: 2757470 [TBL] [Abstract][Full Text] [Related]
31. Coronary collateral blood flow in acute myocardial ischemia is not increased by dihydropyridine-induced coronary vasodilatation. Sjöquist PO; Duker G; Almgren O J Cardiovasc Pharmacol; 1985; 7(4):630-6. PubMed ID: 2410700 [TBL] [Abstract][Full Text] [Related]
32. The renin-angiotensin system modulates the peripheral vascular effects of the calcium antagonist isradipine in anesthetized rabbits. Hof RP; Hof A J Cardiovasc Pharmacol; 1988 Aug; 12(2):233-8. PubMed ID: 2459555 [TBL] [Abstract][Full Text] [Related]
33. Vasodilating effects of the new calcium antagonist benidipine hydrochloride in anesthetized dogs and cats. Karasawa A; Kubo K; Shuto K; Oka T; Nakamizo N Arzneimittelforschung; 1988 Nov; 38(11A):1707-12. PubMed ID: 3219145 [TBL] [Abstract][Full Text] [Related]
34. Cardiovascular effects of the nifedipine analog, CGP 28 392, in the conscious dog. Preuss KC; Cheung NL; Brooks HL; Warltier DC J Cardiovasc Pharmacol; 1984; 6(5):949-53. PubMed ID: 6209505 [TBL] [Abstract][Full Text] [Related]
35. PY 108-068, a new, potent, and selective inhibitor of calcium-induced contraction of rabbit aortic rings. Hof RP; Vuorela HJ; Neumann P J Cardiovasc Pharmacol; 1982; 4(3):344-51. PubMed ID: 6177928 [TBL] [Abstract][Full Text] [Related]
36. Hemodynamic and antianginal effects during rest and exercise of intravenous isradipine, a new dihydropyridine calcium antagonist. Burger W; Neidel S; Kober G Clin Cardiol; 1989 Jul; 12(7):393-8. PubMed ID: 2525975 [TBL] [Abstract][Full Text] [Related]
37. Vasopressin induced myocardial depression in neurally mediated and not due to impaired coronary blood flow. Hof RP Br J Pharmacol; 1986 Mar; 87(3):611-8. PubMed ID: 3801766 [TBL] [Abstract][Full Text] [Related]
38. Effects of nisoldipine, a new calcium antagonist, on myocardial infarct size and cardiac dynamics following acute myocardial infarction. Tumas J; Deth R; Kloner RA J Cardiovasc Pharmacol; 1985; 7(2):361-7. PubMed ID: 2581092 [TBL] [Abstract][Full Text] [Related]
39. [Vasodilator effects of LF 2.0254, a new 1,4-dihydropyridine. Comparison with nifedipine]. Pruneau D; Roy F; Brown NL Therapie; 1989; 44(3):203-8. PubMed ID: 2781506 [TBL] [Abstract][Full Text] [Related]
40. Left ventricular mechanical consequences of dihydropyridine calcium channel modulation in conscious and anesthetized chronically instrumented dogs. Pagel PS; Hettrick DA; Warltier DC Anesthesiology; 1994 Jul; 81(1):190-208. PubMed ID: 7519000 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]